Global Hepatitis A Vaccine Market Growth 2022-2028
- Category: Healthcare
- Published Date: May 2022
- Publisher: LP Information
- Pages: 98
As the global economy mends, the 2021 growth of Hepatitis A Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Hepatitis A Vaccine market size is USD million in 2022 from USD 690.5 million in 2021, with a change of % between 2021 and 2022. The global Hepatitis A Vaccine market size will reach USD 810.9 million in 2028, growing at a CAGR of 2.3% over the analysis period 2022-2028.
The United States Hepatitis A Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Hepatitis A Vaccine market, reaching US$ million by the year 2028. As for the Europe Hepatitis A Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Hepatitis A Vaccine players cover GSK, Merck, Sanofi, and Sinovac, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Inactivated Vaccine
Live Attenuated Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Government Institution
Private Sector
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
The United States Hepatitis A Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Hepatitis A Vaccine market, reaching US$ million by the year 2028. As for the Europe Hepatitis A Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Hepatitis A Vaccine players cover GSK, Merck, Sanofi, and Sinovac, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Inactivated Vaccine
Live Attenuated Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Government Institution
Private Sector
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatitis A Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatitis A Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatitis A Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Hepatitis A Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 Hepatitis A Vaccine Sales by Type
2.3.1 Global Hepatitis A Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatitis A Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatitis A Vaccine Sale Price by Type (2017-2022)
2.4 Hepatitis A Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Hepatitis A Vaccine Sales by Application
2.5.1 Global Hepatitis A Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatitis A Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatitis A Vaccine Sale Price by Application (2017-2022)
3 Global Hepatitis A Vaccine by Company
3.1 Global Hepatitis A Vaccine Breakdown Data by Company
3.1.1 Global Hepatitis A Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Hepatitis A Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Hepatitis A Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatitis A Vaccine Revenue by Company (2020-2022)
3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Hepatitis A Vaccine Sale Price by Company
3.4 Key Manufacturers Hepatitis A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis A Vaccine Product Location Distribution
3.4.2 Players Hepatitis A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hepatitis A Vaccine by Geographic Region
4.1 World Historic Hepatitis A Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatitis A Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatitis A Vaccine Annual Revenue by Geographic Region
4.2 World Historic Hepatitis A Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatitis A Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatitis A Vaccine Annual Revenue by Country/Region
4.3 Americas Hepatitis A Vaccine Sales Growth
4.4 APAC Hepatitis A Vaccine Sales Growth
4.5 Europe Hepatitis A Vaccine Sales Growth
4.6 Middle East & Africa Hepatitis A Vaccine Sales Growth
5 Americas
5.1 Americas Hepatitis A Vaccine Sales by Country
5.1.1 Americas Hepatitis A Vaccine Sales by Country (2017-2022)
5.1.2 Americas Hepatitis A Vaccine Revenue by Country (2017-2022)
5.2 Americas Hepatitis A Vaccine Sales by Type
5.3 Americas Hepatitis A Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis A Vaccine Sales by Region
6.1.1 APAC Hepatitis A Vaccine Sales by Region (2017-2022)
6.1.2 APAC Hepatitis A Vaccine Revenue by Region (2017-2022)
6.2 APAC Hepatitis A Vaccine Sales by Type
6.3 APAC Hepatitis A Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hepatitis A Vaccine by Country
7.1.1 Europe Hepatitis A Vaccine Sales by Country (2017-2022)
7.1.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2022)
7.2 Europe Hepatitis A Vaccine Sales by Type
7.3 Europe Hepatitis A Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hepatitis A Vaccine by Country
8.1.1 Middle East & Africa Hepatitis A Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatitis A Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatitis A Vaccine Sales by Type
8.3 Middle East & Africa Hepatitis A Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis A Vaccine
10.3 Manufacturing Process Analysis of Hepatitis A Vaccine
10.4 Industry Chain Structure of Hepatitis A Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis A Vaccine Distributors
11.3 Hepatitis A Vaccine Customer
12 World Forecast Review for Hepatitis A Vaccine by Geographic Region
12.1 Global Hepatitis A Vaccine Market Size Forecast by Region
12.1.1 Global Hepatitis A Vaccine Forecast by Region (2023-2028)
12.1.2 Global Hepatitis A Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis A Vaccine Forecast by Type
12.7 Global Hepatitis A Vaccine Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Hepatitis A Vaccine Product Offered
13.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Hepatitis A Vaccine Product Offered
13.2.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Hepatitis A Vaccine Product Offered
13.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Hepatitis A Vaccine Product Offered
13.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Hepatitis A Vaccine Product Offered
13.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Hepatitis A Vaccine Product Offered
13.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Hepatitis A Vaccine Product Offered
13.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 IMBCAMS
13.8.1 IMBCAMS Company Information
13.8.2 IMBCAMS Hepatitis A Vaccine Product Offered
13.8.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 IMBCAMS Main Business Overview
13.8.5 IMBCAMS Latest Developments
13.9 Convac
13.9.1 Convac Company Information
13.9.2 Convac Hepatitis A Vaccine Product Offered
13.9.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Convac Main Business Overview
13.9.5 Convac Latest Developments
14 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatitis A Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatitis A Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatitis A Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Hepatitis A Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 Hepatitis A Vaccine Sales by Type
2.3.1 Global Hepatitis A Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatitis A Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatitis A Vaccine Sale Price by Type (2017-2022)
2.4 Hepatitis A Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.4.3 Other
2.5 Hepatitis A Vaccine Sales by Application
2.5.1 Global Hepatitis A Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatitis A Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatitis A Vaccine Sale Price by Application (2017-2022)
3 Global Hepatitis A Vaccine by Company
3.1 Global Hepatitis A Vaccine Breakdown Data by Company
3.1.1 Global Hepatitis A Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Hepatitis A Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Hepatitis A Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatitis A Vaccine Revenue by Company (2020-2022)
3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Hepatitis A Vaccine Sale Price by Company
3.4 Key Manufacturers Hepatitis A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis A Vaccine Product Location Distribution
3.4.2 Players Hepatitis A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hepatitis A Vaccine by Geographic Region
4.1 World Historic Hepatitis A Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatitis A Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatitis A Vaccine Annual Revenue by Geographic Region
4.2 World Historic Hepatitis A Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatitis A Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatitis A Vaccine Annual Revenue by Country/Region
4.3 Americas Hepatitis A Vaccine Sales Growth
4.4 APAC Hepatitis A Vaccine Sales Growth
4.5 Europe Hepatitis A Vaccine Sales Growth
4.6 Middle East & Africa Hepatitis A Vaccine Sales Growth
5 Americas
5.1 Americas Hepatitis A Vaccine Sales by Country
5.1.1 Americas Hepatitis A Vaccine Sales by Country (2017-2022)
5.1.2 Americas Hepatitis A Vaccine Revenue by Country (2017-2022)
5.2 Americas Hepatitis A Vaccine Sales by Type
5.3 Americas Hepatitis A Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis A Vaccine Sales by Region
6.1.1 APAC Hepatitis A Vaccine Sales by Region (2017-2022)
6.1.2 APAC Hepatitis A Vaccine Revenue by Region (2017-2022)
6.2 APAC Hepatitis A Vaccine Sales by Type
6.3 APAC Hepatitis A Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hepatitis A Vaccine by Country
7.1.1 Europe Hepatitis A Vaccine Sales by Country (2017-2022)
7.1.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2022)
7.2 Europe Hepatitis A Vaccine Sales by Type
7.3 Europe Hepatitis A Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hepatitis A Vaccine by Country
8.1.1 Middle East & Africa Hepatitis A Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatitis A Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatitis A Vaccine Sales by Type
8.3 Middle East & Africa Hepatitis A Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis A Vaccine
10.3 Manufacturing Process Analysis of Hepatitis A Vaccine
10.4 Industry Chain Structure of Hepatitis A Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis A Vaccine Distributors
11.3 Hepatitis A Vaccine Customer
12 World Forecast Review for Hepatitis A Vaccine by Geographic Region
12.1 Global Hepatitis A Vaccine Market Size Forecast by Region
12.1.1 Global Hepatitis A Vaccine Forecast by Region (2023-2028)
12.1.2 Global Hepatitis A Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis A Vaccine Forecast by Type
12.7 Global Hepatitis A Vaccine Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Hepatitis A Vaccine Product Offered
13.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Hepatitis A Vaccine Product Offered
13.2.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Hepatitis A Vaccine Product Offered
13.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Sinovac
13.4.1 Sinovac Company Information
13.4.2 Sinovac Hepatitis A Vaccine Product Offered
13.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sinovac Main Business Overview
13.4.5 Sinovac Latest Developments
13.5 Zhejiang Pukang
13.5.1 Zhejiang Pukang Company Information
13.5.2 Zhejiang Pukang Hepatitis A Vaccine Product Offered
13.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zhejiang Pukang Main Business Overview
13.5.5 Zhejiang Pukang Latest Developments
13.6 Changchun Institute of Biological
13.6.1 Changchun Institute of Biological Company Information
13.6.2 Changchun Institute of Biological Hepatitis A Vaccine Product Offered
13.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Changchun Institute of Biological Main Business Overview
13.6.5 Changchun Institute of Biological Latest Developments
13.7 KM Biologics
13.7.1 KM Biologics Company Information
13.7.2 KM Biologics Hepatitis A Vaccine Product Offered
13.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 KM Biologics Main Business Overview
13.7.5 KM Biologics Latest Developments
13.8 IMBCAMS
13.8.1 IMBCAMS Company Information
13.8.2 IMBCAMS Hepatitis A Vaccine Product Offered
13.8.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 IMBCAMS Main Business Overview
13.8.5 IMBCAMS Latest Developments
13.9 Convac
13.9.1 Convac Company Information
13.9.2 Convac Hepatitis A Vaccine Product Offered
13.9.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Convac Main Business Overview
13.9.5 Convac Latest Developments
14 Research Findings and Conclusion
no record found